Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2328-2339

  Fu, Junliang ^a   Xu, Dongping ^a   Liu, Zhenwen ^a   Shi, Ming ^a   Zhao, Ping ^a   Fu, Baoyun ^a   Zhang, Zheng ^a   Yang, Huiyin ^a   Zhang, Hui ^a   Zhou, Chunbao ^a   Yao, Jinxia ^a   Jin, Lei ^a   Wang, Huifen ^a   Yang, Yongping ^a   Fu, Yang Xing ^b,c   Wang, Fu Sheng ^a,c  

^a BEIJING 302 HOSPITAL   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; GRANZYME A; GRANZYME B; PERFORIN; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; GRANZYME; INTERLEUKIN 2 RECEPTOR ALPHA; MEMBRANE PROTEIN; PORE FORMING CYTOTOXIC PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; BLOOD; CANCER STAGING; CD4+ T LYMPHOCYTE; DISEASE COURSE; DRUG ANTAGONISM; ENZYME ACTIVATION; IMMUNOLOGY; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANZYMES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; PORE FORMING CYTOTOXIC PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY;

EID: 34250005419     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.102     Document Type: Article

References (43)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Hao X.S., Wang P.P., Chen K.X., Li Q., He M., Yu S.B., Guo Z.Y., Perruccio A., and Rohan T. Twenty-year trends of primary liver cancer incidence rates in an urban Chinese population. Eur J Cancer Prev 12 (2003) 273-279
3. Zhai Y., Zhou G., Deng G., Xie W., Dong X., Zhang X., Yu L., Yang H., Yuan X., Zhang H., Zhi L., Yao Z., Shen Y., Qiang B., and He F. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Gastroenterology 130 (2006) 2001-2009
4. Rosenberg S.A. Progress in the development of immunotherapy for the treatment of patients with cancer. J Intern Med 250 (2001) 462-475
5. Korangy F., Ormandy L.A., Bleck J.S., Klempnauer J., Wilkens L., Manns M.P., and Greten T.F. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res 10 (2004) 4332-4341
6. Mizukoshi E., Nakamoto Y., Marukawa Y., Arai K., Yamashita T., Tsuji H., Kuzushima K., Takiguchi M., and Kaneko S. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 43 (2006) 1284-1294
7. Liu Y., Daley S., Evdokimova V.N., Zdobinski D.D., Potter D.M., and Butterfield L.H. Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. J Immunol 177 (2006) 712-721
8. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
9. Maul J., Loddenkemper C., Mundt P., Berg E., Giese T., Stallmach A., Zeitz M., and Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128 (2005) 1868-1878
10. Westendorf A.M., Fleissner D., Deppenmeier S., Gruber A.D., Bruder D., Hansen W., Liblau R., and Buer J. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 131 (2006) 510-524
11. Rad R., Brenner L., Bauer S., Schwendy S., Layland L., da Costa C.P., Reindl W., Dossumbekova A., Friedrich M., Saur D., Wagner H., Schmid R.M., and Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 131 (2006) 525-537
12. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., Chuang Y.H., Nakamura T., Saito S., Shimoda S., Tanaka A., Bowlus C.L., Takano Y., Ansari A.A., Coppel R.L., and Gershwin M.E. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
13. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., and Ma Y. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
14. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., and Vergani D. Impairment of CD4(+)CD25(+) regulatory T cells in autoimmune liver disease. J Hepatol 41 (2004) 31-37
15. Sugimoto K., Ikeda F., Stadanlick J., Nunes F.A., Alter H.J., and Chang K.M. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38 (2003) 1437-1448
16. Cabrera R., Tu Z., Xu Y., Firpi R.J., Rosen H.R., Liu C., and Nelson D.R. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40 (2004) 1062-1071
17. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., Blum H.E., von Weizsacker F., and Thimme R. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79 (2005) 7860-7867
18. Franzese O., Kennedy P.T., Gehring A.J., Gotto J., Williams R., Maini M.K., and Bertoletti A. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 79 (2005) 3322-3328
19. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., and Janssen H.L. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41 (2005) 771-778
20. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., and Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 177 (2006) 739-747
21. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S., and Linehan D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169 (2002) 2756-2761
22. Wolf A.M., Wolf D., Steurer M., Gastl G., Gunsilius E., and Grubeck-Loebenstein B. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9 (2003) 606-612
23. Sasada T., Kimura M., Yoshida Y., Kanai M., and Takabayashi A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98 (2003) 1089-1099
24. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., and Fujii H. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9 (2003) 4404-4408
25. Kono K., Kawaida H., Takahashi A., Sugai H., Mimura K., Miyagawa N., Omata H., and Fujii H. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother 55 (2006) 1064-1071
26. Unitt E., Rushbrook S.M., Marshall A., Davies S., Gibbs P., Morris L.S., Coleman N., and Alexander G.J. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41 (2005) 722-730
27. Ormandy L.A., Hillemann T., Wedemeyer H., Manns M.P., Greten T.F., and Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65 (2005) 2457-2464
28. Yang X.H., Yamagiwa S., Ichida T., Matsuda Y., Sugahara S., Watanabe H., Sato Y., Abo T., Horwitz D.A., and Aoyagi Y. Increase of CD4+ CD25+ regulatory T cells in the liver of patients with hepatocellular carcinoma. J Hepatol 45 (2006) 254-262
29. Beyer M., and Schultze J.L. Regulatory T cells in cancer. Blood 108 (2006) 804-811
30. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., and Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10 (2004) 942-949
31. Sheng J.M., Zhao W.H., Wu F.S., Ma Z.M., Feng Y.Z., Zhou X.R., and Teng L.S. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection. Hepatobiliary Pancreat Dis Int 4 (2005) 561-564
32. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243 (2000) 147-154
33. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., and Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 (2003) 65-78
34. Chang K.M. Regulatory T cells and the liver: a new piece of the puzzle. Hepatology 41 (2005) 700-702
35. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., Powrie F., and Banham A.H. Analysis of FOXP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol 36 (2006) 1681-1691
36. Ring S., Schafer S.C., Mahnke K., Lehr H.A., and Enk A.H. CD4(+)CD25(+) regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36 (2006) 2981-2992
37. Yu P., and Fu Y.X. Tumor-infiltrating T lymphocytes: friends or foes?. Lab Invest 86 (2006) 231-245
38. Wang H.Y., Lee D.A., Peng G., Guo Z., Li Y., Kiniwa Y., Shevach E.M., and Wang R.F. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20 (2004) 107-118
39. Baecher-Allan C., and Anderson D.E. Regulatory cells and human cancer. Semin Cancer Biol 16 (2006) 98-105
40. Valzasina B., Piconese S., Guiducci C., and Colombo M.P. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res 66 (2006) 4488-4495
41. Hori S., and Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect 6 (2004) 745-751
42. Yang Z.Z., Novak A.J., Ziesmer S.C., Witzig T.E., and Ansell S.M. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma. Cancer Res 66 (2006) 10145-10152
43. Sato E., Olson S.H., Ahn J., Bundy B., Nishikawa H., Qian F., Jungbluth A.A., Frosina D., Gnjatic S., Ambrosone C., Kepner J., Odunsi T., Ritter G., Lele S., Chen Y.T., Ohtani H., Old L.J., and Odunsi K. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 102 (2005) 18538-18543